Alzheimer's disease normative cerebrospinal fluid biomarkers validated in pet amyloid-β characterized subjects from the Australian imaging, biomarkers and lifestyle (AIBL) study

Qiao Xin Li, Victor L. Villemagne, James D. Doecke, Alan Rembach, Shannon Sarros, Shiji Varghese, Amelia McGlade, Katrina M. Laughton, Kelly K. Pertile, Christopher J. Fowler, Rebecca L. Rumble, Brett O. Trounson, Kevin Taddei, Stephanie R. Rainey-Smith, Simon M. Laws, Joanne S. Robertson, Lisbeth A. Evered, Brendan Silbert, Kathryn A. Ellis, Christopher C. RoweS. Lance Macaulay, David Darby, Ralph N. Martins, David Ames, Colin L. Masters, Steven Collins*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Alzheimer's disease normative cerebrospinal fluid biomarkers validated in pet amyloid-β characterized subjects from the Australian imaging, biomarkers and lifestyle (AIBL) study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences